
<table style="text-align:center"><caption><strong>Poisson Models of Market Authorizations for NEW Orphan Drugs (Not adjusted for Error Structure)</strong></caption>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="6"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="6" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="6">Annual Number of Market Authorizations for NEW Orphan Drugs</td></tr>
<tr><td style="text-align:left"></td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td><td>(6)</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD)</td><td></td><td></td><td>-0.005</td><td>-0.006</td><td>-0.004</td><td>-0.0005</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.008)</td><td>(0.044)</td><td>(0.008)</td><td>(0.045)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">US</td><td>0.879<sup>***</sup></td><td>0.607<sup>***</sup></td><td>0.639<sup>***</sup></td><td>0.626</td><td>0.639<sup>***</sup></td><td>0.700</td></tr>
<tr><td style="text-align:left"></td><td>(0.086)</td><td>(0.196)</td><td>(0.202)</td><td>(0.700)</td><td>(0.202)</td><td>(0.707)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004</td><td>0.075<sup>***</sup></td><td>0.057<sup>***</sup></td><td>0.063<sup>***</sup></td><td>0.064</td><td>0.062<sup>***</sup></td><td>0.057</td></tr>
<tr><td style="text-align:left"></td><td>(0.008)</td><td>(0.014)</td><td>(0.017)</td><td>(0.056)</td><td>(0.017)</td><td>(0.057)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate</td><td></td><td></td><td></td><td></td><td>-1.395</td><td>-1.412</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td>(1.582)</td><td>(1.593)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US</td><td></td><td>0.026</td><td>0.035</td><td>0.034</td><td>0.034</td><td>0.040</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.017)</td><td>(0.022)</td><td>(0.062)</td><td>(0.022)</td><td>(0.062)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US</td><td></td><td></td><td></td><td>0.001</td><td></td><td>-0.004</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.045)</td><td></td><td>(0.046)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept</td><td>1.675<sup>***</sup></td><td>1.866<sup>***</sup></td><td>1.945<sup>***</sup></td><td>1.957<sup>***</sup></td><td>1.949<sup>***</sup></td><td>1.891<sup>***</sup></td></tr>
<tr><td style="text-align:left"></td><td>(0.111)</td><td>(0.162)</td><td>(0.201)</td><td>(0.670)</td><td>(0.202)</td><td>(0.677)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Observations</td><td>35</td><td>35</td><td>35</td><td>35</td><td>35</td><td>35</td></tr>
<tr><td style="text-align:left">Log Likelihood</td><td>-102.920</td><td>-101.765</td><td>-101.545</td><td>-101.544</td><td>-101.161</td><td>-101.157</td></tr>
<tr><td style="text-align:left">Akaike Inf. Crit.</td><td>211.841</td><td>211.531</td><td>213.089</td><td>215.089</td><td>214.322</td><td>216.313</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="6" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
